Log in
Enquire now
‌

US Patent 9394299 Rilyazine derivatives and compositions for the treatment of cancer

Patent 9394299 was granted and assigned to Warner Babcock Institute For Green Chemistry on July, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Warner Babcock Institute For Green Chemistry
Warner Babcock Institute For Green Chemistry
0
Current Assignee
Warner Babcock Institute For Green Chemistry
Warner Babcock Institute For Green Chemistry
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
93942990
Patent Inventor Names
Thomas W. Gero0
Jeffery A. Gladding0
John C. Warner0
Srinivasa R. Cheruku0
Date of Patent
July 19, 2016
0
Patent Application Number
144734720
Date Filed
August 29, 2014
0
Patent Primary Examiner
‌
Paul V Ward
0
Patent abstract

The present application discloses Rilyazine analogs, methods for their preparation, and the treatment of cancer by the administration of an effective amount of the Rilyazine analogs to a patient in need thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9394299 Rilyazine derivatives and compositions for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.